📰 Iagnostics News
Page 118 - Iagnostics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Iagnostics. Real-time updates on events, politics, business and more.
December 20, 2021
Researchers in the US have developed a novel multiplexed diagnostic platform based on CRISPR-based approaches and microfluidics - enabling robust and simultaneous surveillance of multiple viruses and viral variants. Currently, the paper is available on the medRxiv* preprint server pending peer review.
December 20, 2021
On-demand webinar discussing how non-invasive monitoring programs can improve confidence in COVID-19 test results
December 20, 2021
A new study helps to explain the rapid spread of the Delta variant and provides the impetus to increase control measures including vaccine boosters and social distancing requirements.
December 20, 2021
Since the start of the COVID-19 pandemic, variants have begun to emerge. We spoke to Jacob Heggestad about his rapid test that can detect these variants.
December 20, 2021
NBEC 2021 received support from 34 national and international partners
December 18, 2021
Guardion Health Sciences Issues Letter to Shareholders HOUSTON - December 16, 2021 - Guardion Health Sciences, Inc. , a clinical nutrition and diagnostics company that... | December 17, 2021
December 18, 2021
Italian diagnostics firm DiaSorin forecast weaker 2022 sales and a near 60% plunge in COVID-19 revenue, with the rapid rollout of vaccines likely to bring the pandemic under control and crimp... | December 18, 2021
December 17, 2021
New Delhi [India], December 17 (ANI/SRV): As part of its ever expanding drive, Apollo Diagnostics, the diagnostic division of Apollo Health and Lifestyle Limited (AHLL) and part of the Apollo Hospitals Group has forayed into Delhi NCR.
December 17, 2021
R-Biopharm announces that the company’s RIDA®GENE Flu & SARS-CoV-2 multiplex test (PG6825) has been approved in the UK under the UK Health Security Agency’s Medical Devices (Coronavirus Test Device Approvals) Regulations 2021 (“CTDA”).
December 16, 2021
- Homegrown medical technology Company, Acumen Diagnostics Pte. Ltd. , a 51% owned subsidiary of Q&M Dental Group Limited and 49% owned by Aoxin Q&M Dental Group Limited , today announced... | December 16, 2021